Wu Minwan, El-Kattan Yahya, Lin Tsu-Hsing, Ghosh Ajit, Vadlakonda Satish, Kotian Pravin L, Babu Yarlagadda S, Chand Pooran
BioCryst Pharmaceuticals inc., Birmingham, Alabama 35244, USA.
Nucleosides Nucleotides Nucleic Acids. 2005;24(10-12):1543-68. doi: 10.1080/15257770500268673.
Acyclic N9 adenine nucleosides substituted at C-1' position were prepared by the Mitsunobu reaction of 1-tert-butyldimethylsilyl-4-pivaloylbutan-1,2,4-triol (5) with adenine. Pivaloyl hydroxyl was modified to the phosphonomethoxy derivatives, and the tert-butyldimethylsilyl hydroxyl was converted to methoxy, azido, amino, fluoro, and c-hydroxyethyl and was eliminated to give vinyl. The resulting phosphonic acids were converted to prodrugs also.
通过1-叔丁基二甲基甲硅烷基-4-新戊酰基丁烷-1,2,4-三醇(5)与腺嘌呤的 Mitsunobu 反应制备在 C-1' 位被取代的无环 N9 腺嘌呤核苷。新戊酰羟基被修饰为膦酰基甲氧基衍生物,叔丁基二甲基甲硅烷基羟基被转化为甲氧基、叠氮基、氨基、氟以及 c-羟乙基,并被消除得到乙烯基。所得的膦酸也被转化为前药。